Bioelectronics Corp (BIEL)

[Probity]

“Why would another company purchase BIEL at this juncture? It appears BIEL's rights to the patents have expired - so no intellectual property is in play.”

Some company might. My understanding is that when a company’s FDA - cleared product patent expires, another entity cannot use the existing clearance(s) by simply replicating the product. They must submit a new application(s) for FDA clearance that complies with current regulations and guidelines.

How long would that process take?

BIEL has 5 FDA clearances inclusive of musculoskeletal.

Who in their right mind would go through seeking clearances, especially given the NOPAIN Act and possible CMS insurance being right around the corner?